ADAM has been founded as CERN spin-off Company in Geneva on 20th of December 2007 to promote scientific know-how in medical and industrial fields.

As CERN spin-off, ADAM can easily access world-level experts and CERN facilities. Collaboration agreements with Agencies and Companies of strategic importance are underway.

The core of the know-how is the innovative accelerator concept "cyclinac", which produces beams of protons and ions tailored to isotopes production for diagnostics and beams for hadrontherapy.
ADAM has exclusive rights on the present and future know-how of the TERA Foundation.

Our mission

The mission of ADAM is to create a center of excellence for research and industrialization of applications of linear accelerators and detectors. R&D of medical equipment for oncological radiotherapy is its main research sector.
ADAM is also active in the design of advanced control systems for accelerators in industrial fields.